Indrayani Biotech has informed that it enclosed Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on February 17, 2024 for Swaminathan.
The above information is a part of company’s filings submitted to BSE.